Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 7Active not recruiting 3Terminated 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Squamous Cell Carcinoma of Head and Neck 15Head and Neck Neoplasms 10Prostatic Neoplasms 8Rectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Pancreatic Neoplasms 4Glioblastoma 4Urinary Bladder Neoplasms 3Sarcoma 3Oropharyngeal Neoplasms 3Lymphoma, Extranodal NK-T-Cell 3Kidney Neoplasms 3Gliosarcoma 3Brain Neoplasms 3Neoplasm Metastasis 2Mesothelioma, Malignant 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Glioma 2Congenital Abnormalities 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Carcinoma 2Astrocytoma 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Vomiting 1Uterine Cervical Neoplasms 1Stage IA Uterine Sarcoma 1Squamous Cell Carcinoma of Anal Canal 1

Interventions

Temozolomide 22Bevacizumab 10Radiotherapy 5Magnetic Resonance Spectroscopy 5Irinotecan 5Carmustine 4fluorodopa F 18 3Topotecan 3Surgical Procedures, Operative 3Standard of Care 3Radiosurgery 3Magnetic Resonance Imaging 3Congresses as Topic 3Carboplatin 3Aminolevulinic Acid 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3ribociclib 2poly ICLC 2fluoromisonidazole 2carmustine, poliferprosan 20 drug combination 2cabozantinib 2Vorinostat 2TIC10 compound 2Re-Irradiation 2Radiotherapy, Intensity-Modulated 2Panobinostat 2O(6)-benzylguanine 2Melphalan 2Lomustine 2Lacosamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Glioma × Radiotherapy, Intensity-Modulated × Clear all
NCT01263821 2017-08-04

Image Guided Therapy in the Treatment of Gliomas

NYU Langone Health

Phase NA Terminated
15 enrolled
CNS

Glioma

NCT02039778 2017-06-05

STRONG

Beth Israel Medical Center

Phase NA Terminated
4 enrolled 8 charts
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡